nituzumab
mAbexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Aug 15, 2022 (NCT05508347)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06414577 | Phase 2 | May 15, 2024 | Sun Yat-Sen University |
| NCT06455072 | Phase 2 | Feb 1, 2023 | Fujian Medical University, Zhangzhou Municipal Hospital of Fujian Province |
| NCT05831930 | Early Phase 1 (Phase 1) | Jan 17, 2023 | University of Electronic Science and Technology of China |
| NCT05508347 | Phase 2 | Aug 15, 2022 | University of Electronic Science and Technology of China |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Electronic Science and Technology of China | Academic/Hospital | 2 | 2 | 2 | 2022 |
| Fujian Medical University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Zhangzhou Municipal Hospital of Fujian Province | Academic/Hospital | 1 | 0 | 1 | 2023 |
4 organizations
Page 1 / 1